NSW Health Immune Effector Cell Therapy

O'Connell Advisory led development of the NSW Immune Effector Cell Therapy Service Plan for NSW Health, supporting future planning for emerging cancer therapies (e.g. CAR-T) across New South Wales. 

The project included evidence reviews, international horizon scanning, stakeholder consultation, activity modelling, financial analysis and service planning. 

Working closely with clinicians, consumers, government and industry stakeholders, we identified future demand, future requirements and service delivery models needed to support equitable access to these highly specialised therapies.

Client: 
NSW Health - Speciality Service and Technology Evaluation, Strategic Reform and Planning Branch